Literature DB >> 31486490

MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.

X-M Lin1, H Chen, X-L Zhan.   

Abstract

OBJECTIVE: Janus kinase (JAK)- signal transducer and transcriptional activator (STAT) pathway overactivation is closely related to tumorigenesis. Cytokine signal transduction inhibitor 3 (SOCS3) is a negative regulator of JAK-STAT. It is shown that miR-203 is significantly elevated in the pancreatic cancer tissues. The bioinformatics analysis revealed a targeted binding site between miR-203 and the 3'-UTR of SOCS3 mRNA. This study investigated the role of miR-203 in regulating SOCS3 expression and the proliferation and apoptosis of the pancreatic cancer cells. PATIENTS AND METHODS: Quantitative Real Time-PCR (qRT-PCR) was used to detect the expressions of miR-203 and SCOS3 mRNA in tumor tissues and paracancerous tissues. The Dual-Luciferase reporter gene assay was adopted to validate the target interaction between miR-203 and SOCS3. The PANC-1 cells were cultured in vitro and divided into miR-NC group and miR-203 inhibitor group followed by an analysis of the expressions of SOCS3, p-JAK2, and p-STAT3, cell apoptosis by flow cytometry, and cell proliferation by EdU staining.
RESULTS: Compared with the adjacent tissues, miR-203 expression was significantly increased, while SOCS3 mRNA level was significantly declined in the tumor tissues of pancreatic cancer patients. There was a targeted regulatory relationship between miR-203 and SOCS3 mRNA. Compared with those in HPDE6-C7 cells, miR-203 level was upregulated, whereas SOCS3 mRNA and the protein expressions were reduced in pancreatic cancer PANC-1 and BXPC3 cells. The transfection of miR-203 inhibitor significantly increased SOCS3 mRNA and the protein levels, decreased p-JAK2 and p-STAT3 protein expressions, enhanced cell apoptosis, and inhibited cell proliferation in the pancreatic cancer PANC-1 cells.
CONCLUSIONS: Increased miR-203 expression and reduced SOCS3 level are associated with the pathogenesis of pancreatic cancer. MiR-203 can regulate the proliferation and apoptosis of the pancreatic cancer cells by targeting the inhibited SOCS3 expression and regulating the JAK-STAT pathway activity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31486490     DOI: 10.26355/eurrev_201908_18730

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.

Authors:  Atika Al Saqri; Shika Hanif Malgundkar; Fatima Al Kindi; Ishita Gupta; Mansour Al Moundhri; Yahya Tamimi
Journal:  Hum Cell       Date:  2022-05-21       Impact factor: 4.174

Review 2.  Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment.

Authors:  Ying Li; Wenjing Zhao; Yanli Wang; Haiyan Wang; Shanglong Liu
Journal:  J Nanobiotechnology       Date:  2022-05-02       Impact factor: 9.429

Review 3.  Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer.

Authors:  Leonel Pekarek; Oscar Fraile-Martinez; Cielo Garcia-Montero; Miguel A Saez; Ines Barquero-Pozanco; Laura Del Hierro-Marlasca; Patricia de Castro Martinez; Adoración Romero-Bazán; Miguel A Alvarez-Mon; Jorge Monserrat; Natalio García-Honduvilla; Julia Buján; Melchor Alvarez-Mon; Luis G Guijarro; Miguel A Ortega
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

4.  Downregulated miR-203 attenuates IL-β, IL-6, and TNF-α activation in TRAF6-treated human renal mesangial and tubular epithelial cells.

Authors:  Li Zhang; Xingkun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

5.  Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR-760/SOCS3 pathway.

Authors:  Li Li; Poling Yu; Ping Zhang; Huanmei Wu; Qizhen Chen; Shuangdi Li; Yanqiu Wang
Journal:  Cancer Med       Date:  2020-02-05       Impact factor: 4.452

6.  Targeting the JAK/STAT pathway in solid tumors.

Authors:  Zoya Qureshy; Daniel E Johnson; Jennifer R Grandis
Journal:  J Cancer Metastasis Treat       Date:  2020-08-21

7.  Circular RNA Plasmacytoma Variant Translocation 1 (CircPVT1) knockdown ameliorates hypoxia-induced bladder fibrosis by regulating the miR-203/Suppressor of Cytokine Signaling 3 (SOCS3) signaling axis.

Authors:  Teng Li; Yi Xing; Guoxian Zhang; Yan Wang; Yinsheng Wei; Lingang Cui; Shaojin Zhang; Qingwei Wang
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

8.  MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway.

Authors:  Mingguo Cao; Kebin Tian; Weifeng Sun; Jun Xu; Yu Tang; Shilian Wu
Journal:  Exp Ther Med       Date:  2021-12-01       Impact factor: 2.447

9.  Role of STAT3 Expression in Thyroid Cancer: A Meta-Analysis and Systematic Review Based on the Chinese Population.

Authors:  Ya-Nan Liang; Zuwang Zhang; Ji Song; Fuwei Yang; Pan Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-15       Impact factor: 2.650

10.  MicroRNA-203-3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2.

Authors:  Xi-Feng Fu; Hai-Chao Zhao; Chuan-Li Yang; Chang-Zhou Chen; Kang Wang; Fei Gao; Yang-Zhang Tian; Hao-Liang Zhao
Journal:  Oncol Lett       Date:  2021-06-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.